title: Soluble Flt-1 release response to heparin use: implications for dialysis patients?
authors.affiliation: Department of Internal Medicine D, University Hospital Münster, Münster, Germany.
authors.forename: Giovana Seno
authors.initials: GS
authors.lastname: Di Marco
authors.affiliation: Department of Internal Medicine D, University Hospital Münster, Münster, Germany.
authors.forename: Hermann
authors.initials: H
authors.lastname: Pavenstädt
authors.affiliation: Department of Internal Medicine D, University Hospital Münster, Münster, Germany.
authors.forename: Marcus
authors.initials: M
authors.lastname: Brand
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy*; D008297:Male; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011247:Pregnancy; D006435:Renal Dialysis; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood* / Q000187:drug effects*
chemical_list: D000925:Anticoagulants; D006493:Heparin; C501162:FLT1 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1
keywords: cardiovascular disease; dialysis; endothelial function; heparin; sFlt-1